Considered to be an emerging endemic mycosis in Latin America, paracoccidioidomycosis
is characterized by a chronic course and involvement of multiple organs in …

Paracoccidioides brasiliensis and P. lutzii are etiologic agents of paracoccidioidomycosis
(PCM), an important endemic mycosis in Latin America. During its evolution, these fungi …

Coccidioidomycosis (CM) and paracoccidioidomycosis (PCM) are systemic mycoses that
are highly endemic in Latin America and have recently been included on the World Health …

Nanostructured materials including mesoporous silica nanoparticles (MSNs) have attracted
attention due to their recently discovered capability to increase the immune responses …

Human fungal infections remain a major challenge in medicine. Only a limited number of
antifungal drugs are available, which are often related to severe adverse effects. In addition …

Paracoccidioidomycosis (PCM), caused by Paracoccidioides spp, is an important endemic
mycosis in Latin America. There are two recognized Paracoccidioides species, P …

In impoverished nations, the COVID-19 pandemic has led to a widespread occurrence of
deadly fungal diseases like mucormycosis. The limited availability of effective antifungal …

Paracoccidioidomycosis (PCM) is a systemic mycosis caused by the dimorphic fungus within
the genus Paracoccidioides, particularly Paracoccidioides brasiliensis. The traditional …

Pulmonary fibrosis (PF) is considered the most important sequela developed in patients
suffering from the chronic form of paracoccidioidomycosis (PCM), which leads to the loss of …

Paracoccidioidomycosis (PCM) is the most prevalent deep mycosis in Latin America and is
caused by fungi from the Paracoccidioides genus. Virulence factors are important fungal …